By Prince Golez
The fast-paced procurement process will address the shortage of medicines used in coronavirus (Covid-19) treatment in the country, Malacañang said.
Spokesman Harry Roque made the statement in response to the statement of the Department of Health that stocks of the experimental antiviral drugs remdesivir and tocilizumab are running low.
Remdesivir is an antiviral medication originally developed to treat hepatitis C and a cold-like virus called respiratory syncytial virus while tocilizumab is an anti-inflammatory drug for rheumatoid arthritis.
“Makipagugnayan tayo dito sa DOH (Department of Health) dahil merong kapangyarihan ang DOH sa ilalim ng Bayanihan 1 and 2 na mag-angkat ng diretsahan at hindi na dadaan sa Government Procurement Act para sa lahat ng gamot at mga kinakailangan natin dito sa Covid-19 pandemic,” said Roque.
“Inaasahan natin na yung pinabilis na procurement process ang magiging lunas dito sa kakulangan ng ilang mga gamot na kinakailangan natin para gamutin yung nagkakasakit ng Covid-19,” he added.
Source: Latest Politics News Today (Politics.com.ph)
Hello, my name is Jack Sparrow. I'm a 50 year old self-employed Pirate from the Caribbean.
No comments:
Post a Comment